XML 61 R46.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of the Components of Share-Based Compensation Expense
The following table sets forth the share-based compensation for the periods presented:
Year Ended December 31,
202420232022
Cost of goods sold$985 $363 $149 
Research and development43,449 25,750 28,325 
Selling, general, and administrative22,375 17,597 13,411 
Restructuring costs
431 — — 
Total$67,240 $43,710 $41,885 
Schedule of Profit Interest Activity
The following table sets forth the changes in the Company’s outstanding 2021 Omnibus Equity Incentive Plan non-option awards for the years ended December 31, 2024 and 2023:
Number of SharesWeighted
average grant date fair value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Nonvested shares as of December 31, 20229,250,357 $8.52 
Granted9,932,545 $6.12 
Vested(4,630,999)$8.40 — 
Forfeited(898,957)$8.26 
Nonvested shares as of December 31, 202313,652,946 13,652,946 $6.80 
Granted10,449,306 $6.08 
Vested(7,565,367)$6.76 — 
Forfeited(1,710,039)$7.23 
Nonvested shares as of December 31, 202414,826,846 $7.09 
The following table sets forth the changes in the Company’s outstanding 2023 Inducement Plan non-option awards for the year ended December 31, 2024 and 2023:
Number of SharesWeighted
average grant date fair value		Shares Retained to Cover Statutory Minimum Withholding Taxes
Nonvested shares as of December 31, 2022— $— 
Granted1,840,023 $9.04 
Vested(97,510)$9.53 — 
Forfeited(128,050)$9.53 
Nonvested shares as of December 31, 20231,614,463 $8.97 
Granted1,071,639 $6.16 
Vested(548,986)$8.75 — 
Forfeited(269,800)$9.23 
Nonvested shares as of December 31, 20241,867,316 $7.48 
Schedule of Changes in Outstanding Options
The following table sets forth the changes in the Company’s outstanding options in the 2021 Plan for the years ended December 31, 2024 and 2023:

 OptionsWeighted-average exercise priceWeighted-average remaining contractual term (years)Aggregate intrinsic value
Outstanding at December 31, 2022368,875 $10.74 9.07$— 
Granted— $— 
Exercised— $— 
Forfeited or expired(50,667)$11.69 
Outstanding at December 31, 2023318,208 $10.58 8.08$— 
Granted— $— 
Exercised— $— 
Forfeited or expired(17,743)$6.60 
Outstanding at December 31, 2024300,465 $10.82 7.06$— 
Exercisable at December 31, 2024150,225 $10.82 7.06$— 
Vested or expected to vest150,225 $10.82 7.06$— 
The following table sets forth the changes in the Company’s outstanding options for the years ended December 31, 2024 and 2023:

 OptionsWeighted-average exercise priceWeighted-average remaining contractual term (years)Aggregate intrinsic value
Outstanding at December 31, 20221,214,044 $0.16 4.88$6,889 
Exercised(289,364)$0.11 
Forfeited or expired— $— 
Outstanding at December 31, 2023924,680 $0.17 3.82$7,343 
Exercised(297,017)$0.18 
Forfeited or expired— $— 
Outstanding at December 31, 2024627,663 $0.16 2.81$2,470 
Exercisable at December 31, 2024627,663 $0.16 2.81$2,470 
Vested or expected to vest627,663 $0.16 2.81$2,470